ERYTECH Pharma S.A. Operating Income 2011-2026 | ERYP

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income ERYTECH Pharma S.A.

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-56.5 M	-68.8 M	-64.1 M	-43.6 M	-30.9 M	-22.4 M	-15.6 M	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
-15.6 M	-68.8 M	-43.1 M

Operating Income of other stocks in the Biotechnology industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-508 M	-	2.43 %	$ 254 M	Germany
AbCellera Biologics ABCL	-217 M	$ 3.55	-0.28 %	$ 1.06 B	Canada
Acorda Therapeutics ACOR	-265 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	-16.7 M	-	4.01 %	$ 150 M	Canada
Advaxis ADXS	-36.3 M	-	-9.65 %	$ 45.9 M	USA
AC Immune SA ACIU	-79 M	$ 3.26	4.15 %	$ 229 M	Schweiz
Aeglea BioTherapeutics AGLE	-210 M	-	-	$ 1.01 B	USA
AgeX Therapeutics AGE	-9.89 M	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	-26.8 M	-	-13.47 %	$ 169 M	France
Albireo Pharma ALBO	-123 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	-65.1 M	-	10.36 %	$ 9.8 M	USA
ADC Therapeutics SA ADCT	-262 M	$ 4.14	-1.9 %	$ 105 M	Schweiz
Midatech Pharma plc MTP	-7 M	-	-18.52 %	$ 27.3 M	Britain
Arcturus Therapeutics Holdings ARCT	-76.3 M	$ 6.55	-1.16 %	$ 179 M	Israel
argenx SE ARGX	-349 M	$ 711.17	1.12 %	$ 25 B	Niderland
Adverum Biotechnologies ADVM	-139 M	-	-	$ 86.2 M	USA
Ascendis Pharma A/S ASND	-452 M	$ 230.22	-0.35 %	$ 5 B	Danmark
BioCardia BCDA	-11.6 M	$ 1.3	1.97 %	$ 27.5 M	USA
Applied Genetic Technologies Corporation AGTC	-17.7 M	-	-	$ 26.5 M	USA
Applied Molecular Transport AMTI	-127 M	-	-	$ 10.1 M	USA
Atea Pharmaceuticals AVIR	-181 M	$ 6.12	1.16 %	$ 499 M	USA
Akero Therapeutics AKRO	-285 M	-	-	$ 3.67 B	USA
Athersys ATHX	-87.1 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	-86.8 M	-	0.23 %	$ 488 M	USA
Acer Therapeutics ACER	-24.6 M	-	2.71 %	$ 14 M	USA
ARCA biopharma ABIO	-88.1 M	-	1052.0 %	$ 415 M	USA
Allena Pharmaceuticals ALNA	-47.6 M	-	3.16 %	$ 1.9 M	USA
Can-Fite BioPharma Ltd. CANF	-8.13 M	$ 3.43	-4.19 %	$ 7.46 B	Israel
Aeterna Zentaris AEZS	-8.67 M	-	5.93 %	$ 314 M	Canada
Catalyst Biosciences CBIO	11.5 M	$ 11.3	-2.46 %	$ 1.01 B	USA
AlloVir ALVR	-65.4 M	-	4.14 %	$ 49.1 M	USA
Anika Therapeutics ANIK	-87.6 M	$ 14.59	1.6 %	$ 214 M	USA
Aptinyx APTX	-62.6 M	-	-39.0 %	$ 4.57 M	USA
CNS Pharmaceuticals CNSP	-14.9 M	$ 2.4	-2.04 %	$ 917 K	USA
AVEO Pharmaceuticals AVEO	-49.6 M	-	-	$ 521 M	USA
Ayala Pharmaceuticals AYLA	-37.5 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	-7.83 M	$ 2.63	-0.57 %	$ 16.5 M	USA
Avenue Therapeutics ATXI	-11.3 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	-241 M	$ 1.52	0.33 %	$ 388 M	Britain
BioNTech SE BNTX	15.3 B	$ 94.73	4.62 %	$ 27.2 B	Germany
Athira Pharma ATHA	-101 M	-	-	$ 269 M	USA
CureVac N.V. CVAC	-412 M	-	-	$ 867 M	Germany
Aravive ARAV	-70.8 M	-	-13.39 %	$ 1.45 M	USA